Abstract
Aims: Phenotypic heterogeneity allows individual cells to behave different from the bulk. This non-genetic variability provides a critical route to therapeutic resistance and relapse of cancer. Herein, we characterize phenotypic dynamics that generate an intrinsic and pre-existent, drug-tolerant state and identify a resistance biomarker profile to detect these ‘persister’ cells in skin lesions of CTCL.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
